IP Library › Assignment 024095/0533
Patent Assignment
Reel/Frame 024095/0533

Assignment of Assignor's Interest

Recorded: 2010-03-17 Pages: 2
Assignors
SCHROTH, GARY P.
Executed: 2009-11-21
NELSON, NORMAN C.
Executed: 2009-12-17
Assignee
GEN-PROBE INCORPORATED
10210 GENETIC CENTER DRIVE, MAIL STOP #1 / PATENT DEPT., SAN DIEGO, CALIFORNIA, 92121
Covered Property (1)
Method for Making Available a Priming Oligonucleotide
Patent: 7,939,260 →
Application: 12/389,993 →
Publication: US 2009/0170168
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
Security Interest Release Reel/Frame 028810/0745 Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
Reel/Frame 035820/0239 →
Security Agreement Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 028810 Frame: 0745. Assignor(S) Hereby Confirms the Security Agreement. Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release. Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
Reel/Frame 044727/0529 →
Release of Security Interest Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 075566/0039 →